Fenosa^®

Regorafenib

Product Information

Proprietary Name: Fenosa®
Generic Name: Regorafenib
Dosage Form: Film-coated Tablet
Strengths: 40 mg
Indications: Colorectal Cancer, Gastrointestinal Stromal Tumors, Hepatocellular Carcinoma

Download Leaflet

Oncology

Fenosa®

Regorafenib is indicated for the treatment of colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma.

Apply for a Job Position

Curious about job opportunities?

Signup for a job

Products

Support

Company

Follow Us

© NanoAlvand. All rights reserved. Powered by ِDGN.